{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:49:10Z","timestamp":1791218950574,"version":"4.1.0"},"reference-count":29,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Our study measured the body composition of Diffuse large B-cell lymphoma (DLBCL) patients receiving rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) regimen by computed tomographic (CT) and assessed their correlation with treatment-related toxicity and other adverse outcomes. Methods: We retrospectively analyzed 201 DLBCL patients who underwent pre-treatment abdominal CT examination. CT images were used to assess body composition metrics at the third lumbar vertebrae including fat tissues and muscle. Based on the skeletal muscle area (SMA) and density (SMD), skeletal muscle index (SMI), skeletal muscle gauge (SMG = SMI \u00d7 SMD) and lean body mass (LBM) were calculated. Also analyzed were the toxicity, adverse events and survival. Results: We found that SMG, SMD, SMI and LBM were correlated with any grade 3\u20134 toxicity, dose reduction, hospitalization or termination of the treatment due to immunochemotherapy and worse survival. However, multivariate analysis demonstrated SMG [progression-free survival (PFS): hazard ratio (HR), 2.889; 95% CI, 1.401\u20135.959; p = 0.004; overall survival (OS): HR, 2.655; 95% CI, 1.218\u20135.787; p = 0.014] was the best predictor of poor prognosis. Conclusions: SMG, SMD, SMI and LBM were identified as predictors of adverse reactions and poor survival. SMG was an innovative and valuable indicator of immunochemotherapy toxicity and other adverse outcomes. Additionally, it can be used to individualize antineoplastic drug dosing.<\/jats:p>","DOI":"10.3390\/curroncol28020126","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T14:08:16Z","timestamp":1616508496000},"page":"1325-1337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy"],"prefix":"10.3390","volume":"28","author":[{"given":"Jiaxun","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[{"name":"Radiology Department, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijia","family":"Xuan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","article-title":"Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lym-phoma: A comprehensive review","volume":"14","author":"Camicia","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"41242","DOI":"10.18632\/oncotarget.9271","article-title":"A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/annonc\/mdv019","article-title":"Genetic lesions in diffuse large B-cell lymphomas","volume":"26","author":"Testoni","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2169\/internalmedicine.8291-16","article-title":"3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis","volume":"56","author":"Araie","year":"2017","journal-title":"Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/10428190009089435","article-title":"A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin\u2019s lymphoma","volume":"37","author":"Intragumtornchai","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of Sarcopenia among the Elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am. J. Epidemiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jpeds.2010.04.064","article-title":"Relationship between Chronic Transfusion Therapy and Body Composition in Subjects with Thalassemia","volume":"157","author":"Fung","year":"2010","journal-title":"J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Boudou-Rouquette, P., Narjoz, C., Golmard, J.L., Thomas-Schoemann, A., Mir, O., Taieb, F., Durand, J., Coriat, R., Dauphin, A., and Vidal, M. (2012). Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic poly-morphism in patients with solid tumors: A preliminary study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042875"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/1078155215587345","article-title":"Effects of gender on capecitabine toxicity in colorectal cancer","volume":"22","author":"Ilich","year":"2015","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cam4.621","article-title":"Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens","volume":"5","author":"Ali","year":"2016","journal-title":"Cancer Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2125.2002.01598.x","article-title":"Relationships between body composition parameters and fluorouracil pharmacokinetics","volume":"54","author":"Gusella","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1200\/JCO.1998.16.7.2299","article-title":"Factors affecting epirubicin pharmacokinetics and toxicity: Evidence against using body-surface area for dose calculation","volume":"16","author":"Gurney","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/obr.12187","article-title":"Functional body composition and related aspects in research on obesity and cachexia: Report on the 12th Stock Conference held on 6 and 7 September 2013 in Hamburg, Germany","volume":"15","author":"Baracos","year":"2014","journal-title":"Obes. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<796::AID-CNCR10>3.0.CO;2-P","article-title":"The predictive value of body protein for chemotherapy-induced toxicity","volume":"88","author":"Aslani","year":"2000","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wu, W., Liu, X., Chaftari, P., Carreras, M.T.C., Gonzalez, C., Viets-Upchurch, J., Merriman, K., Tu, S., Dalal, S., and Yeung, S.J. (2015). Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: A retro-spective review. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122047"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2015.07.001","article-title":"Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer","volume":"90","author":"Benth","year":"2015","journal-title":"Lung Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jc.2004-1306","article-title":"Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid Diseases","volume":"90","author":"Santini","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2165\/00003088-199426040-00005","article-title":"Lean Body Mass as a Predictor of Drug Dosage. Implications for Drug Therapy","volume":"26","author":"Morgan","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/bjc.2016.431","article-title":"The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma","volume":"116","author":"Daly","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cam4.571","article-title":"Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients","volume":"5","author":"Iwase","year":"2016","journal-title":"Cancer Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","article-title":"Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Met-astatic Breast Cancer Receiving Taxane-Based Chemotherapy","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/10428194.2013.816421","article-title":"Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"55","author":"Lanic","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chu, M.P., Lieffers, J., Ghosh, S., Belch, A.R., Chua, N.S., Fontaine, A., Sangha, R., Turner, A.R., Baracos, V.E., and Sawyer, M.B. (2015). Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127589"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1158\/1078-0432.CCR-16-2266","article-title":"Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane\u2013Based Chemotherapy for Early-Stage Breast Cancer","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2011-09-380949","article-title":"The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL","volume":"119","author":"Murawski","year":"2012","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2010.01541.x","article-title":"Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemo-therapy","volume":"86","author":"Taskinen","year":"2011","journal-title":"Eur. J. Haematol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/2\/126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:39:39Z","timestamp":1760161179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/2\/126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["curroncol28020126"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28020126","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]}}}